The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12465
StudyName: Eligibility Rosuvastatin Acute Coronary Syndrome NCT01241903
Date of export from the portal: 02.07.2020
Date of Upload / last change: 21.11.2015
License: Creative Commons BY 4.0

----

Description: 
The central hypothesis for this work is that platelet - leukocyte interactions play a critical role in the pathogenesis of acute ischemic events. The primary objective of the study is to determine if early, high-dose administration of the HMG-CoA reductase inhibitor rosuvastatin in the setting of acute coronary syndrome and percutaneous coronary intervention exerts beneficial vascular effects by reducing platelet - leukocyte interactions.
https://clinicaltrials.gov/ct2/show/NCT01241903
